Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

sartorius-fahnen-2020

RoosterBio and Sartorius collaborate to scale up cell and gene therapy manufacturing

January 15, 2021 Medical Communications RoosterBio, Sartorius

RoosterBio, a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media and hMSC bioprocess systems, …
News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi gets EU and UK approval for new dosing option

January 15, 2021 Medical Communications AstraZeneca, Cancer, Imfinzi

AstraZeneca’s Imfinzi (durvalumab) has been approved in the EU and the UK for an additional dosing option in locally advanced, …
News
alexion_sign2

Alexion pauses Phase III ULTOMIRIS COVID-19 trial enrolment

January 15, 2021 Medical Communications Alexion, COVID-19

Alexion has paused further enrolment in the global Phase III study of ULTOMIRIS (ravulizumab-cwvz) in adult COVID-19 patients requiring mechanical …
News

NICE recommends GSK’s ZEJULA for advanced ovarian cancer

January 15, 2021 Medical Communications Cancer, GlaxoSmithKline, NICE

NICE has recommended the use of GlaxoSmithKline’s ZEJULA (niraparib) on the NHS in England for adult women with advanced high-grade …
News
richard_francis

Purespring Therapeutics to appoint Richard Francis as CEO

January 11, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …
Appointment
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

January 8, 2021 Medical Communications

Almost all of Pharmafile.com’s most popular stories this week focused on developments in the global mission to vaccinate against COVID-19. …
News

Pfizer’s COVID-19 vaccine protects against variants, research shows

January 8, 2021 Medical Communications COVID-19, Pfizer, Vaccine

Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …
News

Bayer and CureVac to collaborate on COVID-19 vaccine candidate

January 8, 2021 Medical Communications Bayer, COVID-19, Vaccine

Bayer is joining forces with CureVac, a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), on its COVID-19 …
News
bham_uni

Birmingham research paves way for new anti-fibrotic glaucoma treatment

January 8, 2021 Medical Communications Glaucoma, University of Birmingham

New research from the University of Birmingham has shown that a novel low molecular weight dextran-sulphate, ILB, could play a …
News

Arthritis drugs could save lives of COVID-19 patients, study finds

January 8, 2021 Medical Communications COVID-19

Two drugs used to treat rheumatoid arthritis could cut COVID-19 hospital stays by as much as 10 days, and save …
News
moderna_norwood_plant

EU approves Moderna’s COVID-19 vaccine

January 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …
News
herbert

Clinigen appoints Sam Herbert as Chief Operating Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
Appointment
screenshot_2021-01-05_puretech_announces_the_appointment_of_george_farmer_ph_d__as_chief_financial_officer_biospace

PureTech appoints George Farmer as Chief Financial Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …
Appointment
1517679969844

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

December 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …
Appointment

The importance of ethics and patient centricity in managed and early access programmes

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026